News
GUARD strengthens rare disease research
Tomorrow, not coincidentally on Rare Diseases Day, the GUARD consortium is being launched. GUARD stands for Ghent University Action on Rare Diseases and aims to improve research into and treatment of rare diseases.
Top CEO Marianne De Backer is Ghent University Alumnus of the Year 2024
She is a trail-blazer in the world of biotechnology. Not only as CEO of Vir Biotechnology but also as champion of women in leadership positions she excels. That is why Marianne De Backer is the Ghent University Alumnus of the Year 2024.
Revolutionizing Bovine Mastitis Control: Prof. dr. Sarne De Vliegher's Innovative Approach
IOF-Funded Project Targets Non-Antibiotic Solutions for Dairy Industry's Crucial Challenge